On July 26, 2024, Piramal Pharma Limited announced its unaudited financial results (both standalone and consolidated) for the quarter ending June 30, 2024. Key Highlights for Q1 FY25 In the first quarter of FY25, Piramal Pharma saw a 12% year-over-year increase in revenue from operations, primarily due to strong growth in the CDMO sector and …


